Filing Flows › Citius Oncology (CTOR) › How it makes money
How Citius Oncology (CTOR) makes money
Citius Oncology (CTOR) made $1.5M of revenue in the third quarter fiscal 2026 (Q3 FY26).
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 FY26 | % of revenue |
|---|---|---|
| Revenue | $1.5M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 FY26 | $1.5M | — |
| Q2 FY26 | $1.7M | — |
| Q1 FY26 | $3.9M | — |
From Citius Oncology's 10-Q filed Aug 14, 2026 (on EDGAR).
Questions
How does Citius Oncology make money?
Citius Oncology (CTOR) made $1.5M of revenue in the third quarter fiscal 2026 (Q3 FY26).
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.